Login
Firm Profiles
Newsletter
Partnership
About
The Riverside Company
Firm Website
The Riverside Company Profile
All Strategies: Special Situations, Buyout
Headquarters: New York, NY
BETA - firm profiles early launch
Investor Type
LTM Investments
LTM Exits
The Riverside Company RECENT TRANSACTIONS
wdt_ID
Date
Target
Value
Type
Strategy
Buyers
Sellers
TEV / LTM EBITDA
TEV/LTM Revenue
20001
2023-09-28
Nordsec Ltd
100
Private Placement
Growth/Private Equity
Warburg Pincus; Novator Partners; Burda Principal Investments Gmbh & Co. Kg
-
-
-
20002
2023-09-28
Harbinger Health, Inc.
140
Private Placement
Venture
Flagship Pioneering; Banque Pictet & Cie SA; M&G Investment Management Limited; Partners Group Holding AG (SWX:PGHN)
-
-
-
20003
2023-09-27
Sitryx Therapeutics
39
Private Placement
Growth/Private Equity
Oxford Science Enterprises
-
-
-
20004
2023-09-27
Automera Pte. Ltd.
16
Private Placement
Venture
EDBI; Accelerator Life Science Partners; Xora Innovation; ClavystBio
-
-
-
20005
2023-09-27
Avalyn Pharma Inc.
175
Private Placement
Growth/Private Equity
NVP Associates; RiverVest Venture Management; Novo Holdings A/S; Perceptive Advisors; T. Rowe Price Associates Inc.; Citadel Advisors; Eventide Asset Management; Rock Springs Capital Management LP; Impresa Management; Wellington Management Company; Pivota
-
-
-
Date
Target
Value
Type
Strategy
Buyers
Sellers
TEV / LTM EBITDA
TEV/LTM Revenue
The Riverside Company RECENT EXITS
wdt_ID
Date
Target
Value
Transaction Type
Investment Type
Buyers
Sellers
TEV / LTM EBITDA
TEV/LTM Revenue
20001
2023-09-28
Nordsec Ltd
100
Private Placement
Growth/Private Equity
Warburg Pincus; Novator Partners; Burda Principal Investments Gmbh & Co. Kg
-
-
-
20002
2023-09-28
Harbinger Health, Inc.
140
Private Placement
Venture
Flagship Pioneering; Banque Pictet & Cie SA; M&G Investment Management Limited; Partners Group Holding AG (SWX:PGHN)
-
-
-
20003
2023-09-27
Sitryx Therapeutics
39
Private Placement
Growth/Private Equity
Oxford Science Enterprises
-
-
-
20004
2023-09-27
Automera Pte. Ltd.
16
Private Placement
Venture
EDBI; Accelerator Life Science Partners; Xora Innovation; ClavystBio
-
-
-
20005
2023-09-27
Avalyn Pharma Inc.
175
Private Placement
Growth/Private Equity
NVP Associates; RiverVest Venture Management; Novo Holdings A/S; Perceptive Advisors; T. Rowe Price Associates Inc.; Citadel Advisors; Eventide Asset Management; Rock Springs Capital Management LP; Impresa Management; Wellington Management Company; Pivota
-
-
-
20006
2023-09-27
EchoMark, Inc.
10
Private Placement
Venture
Craft Ventures
-
-
-
20007
2023-09-27
Revefi, Inc.
10
Private Placement
Venture
GTMfund; Neythri Futures Fund
-
-
-
20008
2023-09-27
VanillaSoft, Inc.
0
Private Placement
Growth/Private Equity
Tritium Partners
-
-
-
20009
2023-09-27
BioProtect Ltd.
28
Private Placement
Growth/Private Equity
MVM Partners; Peregrine Ventures; KB Investment Co..; Vincos Limited; Triventures; Almeda Ventures Limited Partnership (TASE:AMDA)
-
-
-
20010
2023-09-27
CellFE Inc.
22
Private Placement
Venture
Khosla Ventures; Greatpoint Investment Management; EGB Capital Invest GmbH; Merck Ventures B.V.; Cota Capital Management; Embark Ventures; Dynamk Capital; Elm Ventures; Riverine Ventures
-
-
-
Date
Target
Value
Transaction Type
Investment Type
Buyers
Sellers
TEV / LTM EBITDA
TEV/LTM Revenue
The Riverside Company RETURNS BY FUND
wdt_ID
Fund
Vintage
Net IRR
MOIC
1
57 Stars
2009
8.0%
1.6x
2
57 Stars 2
2007
6.0%
1.4x
3
AACP AP Investors, L.P.
2007
2.1%
1.1x
4
AACP China Growth Investors
2007
7.9%
1.6x
5
AACP India Investors B
2007
13.0%
4.0x
Fund
Vintage
Net IRR
MOIC
RELATED FIRMS
BDT Capital Partners Profile
Read more
Quad-C Management Profile
Read more
Clayton, Dubilier & Rice (CD&R) Profile
Read more
Accel-KKR Profile
Read more
Platinum Equity Profile
Read more
Diligence Platform
Coming Soon
Private Equity Data
Firm Profiles
Newsletter
Subscribe
Advertise
Archive
Company
About
Contact
Privacy Policy
Terms of Service
×
Dynamic title for modals
Are you sure?
Please confirm deletion. There is no undo!
